Philadelphias

Veteran Legal Teams Step Up to Navigate Philadelphia’s Hair Relaxer Mass Tort Case

by

Philadelphia, Pennsylvania, is gearing up for a significant legal battle as attorneys with extensive experience in mass tort litigation have been selected to lead a high-profile case involving hair relaxer products. The lawsuits stem from claims that these products may be linked to serious health issues, including uterine cancer and other ailments affecting women who have used them. The recent consolidation of cases highlights the increasing scrutiny on the beauty industry, particularly regarding the potential risks associated with chemical hair treatments. Law firms familiar with mass torts have stepped forward to represent the growing number … Read more

$1.1 Billion Risperdal Settlement a Landmark Victory for Plaintiffs in Philadelphia’s Mass Tort History

by

Philadelphia, PA — The sprawling legal battle over Risperdal, once involving over 7,000 cases, has largely concluded with settlements that encompass a total of up to $1.1 billion. The litigation revolved around allegations that the drug, often prescribed off-label, led to the development of gynecomastia in young men and boys, a condition characterized by the growth of breast tissue. The resolution of these cases marked a significant moment in the city’s Complex Litigation Center, noted for handling one of the largest mass torts in its history. This litigation was notable not only for its size … Read more

Philadelphia’s Anapol Weiss Merges with D.C.’s Top Legal Minds, Expanding Its Reach in Personal Injury Law

by

Philadelphia, PA – Anapol Weiss, a law firm specializing in mass torts and personal injury, has officially expanded its operations to Washington, D.C., incorporating a team of five skilled attorneys led by Alexandra Walsh, a notable former partner and founder at Wilkinson Stekloff LLP. This strategic move brings the firm’s deep legal expertise and client-focused approach into the heart of the nation’s capital. The integration of a seasoned legal team into Anapol Weiss marks a significant step in the firm’s growth strategy, enhancing its capabilities and reach in handling complex legal challenges across different jurisdictions. … Read more

Philadelphia’s Risperdal Litigation Nears End with Monumental $1.1 Billion Settlement Agreement

by

Philadelphia, PA — In what marks a significant resolution, nearly all lawsuits in Philadelphia involving the antipsychotic drug Risperdal have been settled for up to $1.1 billion. This settlement addresses claims that the drug, produced by Johnson & Johnson’s subsidiary Janssen Pharmaceuticals, led to adverse effects such as gynecomastia, a condition characterized by breast tissue enlargement in males. The legal battles, accumulating over years, primarily involved male plaintiffs who alleged that Risperdal, prescribed to treat schizophrenia and bipolar disorder, caused them to develop breasts after taking the medication. Many of the lawsuits also claimed that … Read more